Synonyms: example 77 [WO2018090939]
Compound class:
Synthetic organic
Comment: The chemical structure for potrasertib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a serine/ threonine kinase inhibitor with antineoplastic action. Structure match in patents indicates that potrasertib is a Wee1 kinase inhibitor [1-2] (assignee Impact Therapeutics). Impact Therapeutics' pipeline declares one Wee1 inhibitor with code IMP7068, so this might be potrasertib.
|
|
References |
1. Cai SX, Tian YE. (2018)
8,9-dihydroimidazole[1,2-a]pyrimido[5,4-e]pyrimidine-5(6h)-ketone compound. Patent number: WO2018090939A1. Assignee: IMPACT THERAPEUTICS. Priority date: 16/11/2017. Publication date: 24/05/2018. |
2. Tian YE, Cai SX, Guo M, Hsieh CY, Wang R, Zhou R. (2022)
Use of wee1 kinase inhibitors in the treatment of cancer. Patent number: WO2022188802A1. Assignee: Impact Therapeutics (Shanghai). Priority date: 09/03/2022. Publication date: 15/09/2022. |